London, United Kingdom

Michael Bogenstaetter

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Bogenstaetter. Retrieved from https://idiyas.com/inventor/michael-bogenstaetter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Bogenstaetter: Innovator in Pharmaceutical Compounds

Introduction

Michael Bogenstaetter is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on imidazole compounds. His expertise and creativity have led to the development of novel compounds that hold promise for various applications.

Latest Patents

Bogenstaetter holds a patent for 2-Oxy, 2-Amino, and 2-Thio-imidazole compounds. This invention relates to novel compounds of formula (I), which are expected to have various beneficial properties in pharmaceutical applications. His patent showcases his ability to create unique chemical structures that can potentially lead to new therapeutic options.

Career Highlights

Michael Bogenstaetter is associated with Ortho-McNeil Pharmaceutical Corporation, where he has been able to apply his innovative ideas in a professional setting. His work at the company has allowed him to collaborate with other talented individuals in the pharmaceutical industry, further enhancing his contributions to the field.

Collaborations

Bogenstaetter has worked alongside notable colleagues such as Nicholas I Carruthers and Jill A Jablonowski. These collaborations have likely enriched his research and development efforts, leading to more comprehensive and effective pharmaceutical solutions.

Conclusion

Michael Bogenstaetter is a distinguished inventor whose work on imidazole compounds has the potential to impact the pharmaceutical industry significantly. His innovative spirit and collaborative efforts continue to drive advancements in this vital field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…